Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-10-07 6:10 pm Purchase | 13D | BIONOMICS LTD ADS BNOX | Apeiron Investment Group Ltd. | 276,490,501 8.900% | 276,490,501 (New Position) | View |
2024-09-30 09:31 am Purchase | 13G | REZOLVE AI Ltd RZLV | Apeiron Investment Group Ltd. | 18,281,638 10.400% | 18,281,638 (New Position) | View |
2024-02-13 4:29 pm Purchase | 13G | ATAI Life Sciences N.V. ATAI | Apeiron Investment Group Ltd. | 33,885,999 20.100% | 1,214,297 (+3.72%) | View |
2023-06-02 5:00 pm Sale | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 0 0.000% | -3,441,661 (Position Closed) | View |
2023-05-23 4:50 pm Unchanged | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 3,441,661 11.100% | 0 (Unchanged) | View |
2023-03-09 5:15 pm Purchase | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 3,441,661 11.200% | 2,200 (+0.06%) | View |
2023-02-10 08:39 am Purchase | 13G | ATAI Life Sciences N.V. ATAI | Apeiron Investment Group Ltd. | 32,671,702 19.400% | 612,198 (+1.91%) | View |
2022-11-21 06:15 am Unchanged | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 3,439,461 11.200% | 0 (Unchanged) | View |
2022-11-02 11:58 am Unchanged | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 3,439,461 11.200% | 0 (Unchanged) | View |
2022-07-19 5:30 pm Purchase | 13D | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 3,439,461 11.200% | 210,000 (+6.50%) | View |
2022-02-10 5:15 pm Purchase | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 3,229,461 10.600% | 577,618 (+21.78%) | View |
2022-02-10 5:01 pm Purchase | 13G | ATAI Life Sciences N.V. ATAI | Apeiron Investment Group Ltd. | 32,059,504 19.700% | 32,059,504 (New Position) | View |
2021-12-30 4:31 pm Purchase | 13D | BIONOMICS LTD ADS BNOX | Apeiron Investment Group Ltd. | 402,550,387 27.700% | 402,550,387 (New Position) | View |
2021-02-18 4:15 pm Purchase | 13G | SENSEI BIOTHERAPEUTICS INC SNSE | Apeiron Investment Group Ltd. | 2,651,843 8.700% | 2,651,843 (New Position) | View |